ALB and neoplasm: In this study, it was shown that PMX was able to increase the tumor-to-kidney ratio of the albumin-binding radiofolate by a factor of ~1.3 at 4 h p.i. and by a factor of 1.5–1.7 at 24 h p.i. in the KB tumor mouse model.